POLARITYTE
PolarityTE is focused on transforming the lives of patients by discovering, designing, and developing a range of regenerative tissue products and biomaterials for the fields of medicine, biomedical engineering and material sciences. Rather than manufacturing with synthetic and foreign materials within artificially engineered environments, PolarityTE manufactures products from the patient's own tissue and uses the patient's own body to support the regenerative process. From a small piece of healthy autologous tissue, the company creates an easily deployable, dynamic, and self-propagating product designed to regenerate the target tissues. PolarityTE's innovative methods are intended to promote and accelerate growth of the patient's tissues to undergo a form of effective regenerative healing.
POLARITYTE
Industry:
Biotechnology Medical
Founded:
1998-05-01
Address:
Salt Lake City, Utah, United States
Country:
United States
Website Url:
http://www.polarityte.com
Total Employee:
11+
Status:
Active
Total Funding:
30.5 M USD
Technology used in webpage:
Domain Not Resolving Google Maps DNSSEC IPv6 Google Maps API Microsoft Ruby On Rails Token Google Adsense Envoy Google Maps For Work
Similar Organizations
Bhang
Bhang Chocolate is dedicated to crafting the finest gourmet chocolate, from high quality ingredients to ensure the greatest possible
Edison Pharmaceuticals
Edison Pharmaceuticals develops medicines for the treatments of children and adults diagnosed with rare and neglected diseases.
Illumina
Illumina is an innovative technology and revolutionary assays aiming the analyze genetic variation and function.
NGM Biopharmaceuticals
NGM Biopharmaceuticals is a drug discovery company developing biotherapeutics for the gastrointestinal endocrine system.
PhaseBio Pharmaceuticals
PhaseBio is a clinical-stage biopharmaceutical company that develops drugs for cardiovascular diseases, endocrine, and metabolic disorders.
Current Employees Featured
Founder
Stock Details
Investors List
Avenue Capital Group
Avenue Capital Group investment in Post-IPO Debt - PolarityTE
Official Site Inspections
http://www.polarityte.com Semrush global rank: 8.69 M Semrush visits lastest month: 588
- Host name: 198.185.159.144
- IP address: 198.185.159.144
- Location: New York United States
- Latitude: 40.7157
- Longitude: -74
- Metro Code: 501
- Timezone: America/New_York
- Postal: 10013
More informations about "PolarityTE"
PolarityTE - Crunchbase Company Profile & Funding
PolarityTE manufactures products from the patient's own tissue and uses the patient's own body to support the regenerative process. From a small piece of healthy autologous tissue, the …See details»
PolarityBio | Revolutionizing Healing with Multicomponent Biologics
Feb 20, 2025 PolarityTE Headquarters 1960 South 4250 West Salt Lake City, UT 84104. Investor Relations Parker Scott [email protected]. Call Us Corporate Main: 800-560-3983. …See details»
PolarityTE - AnnualReports.com
PolarityTE is a commercial-stage biotechnology and regenerative biomaterials company focused on transforming the lives of patients by discovering, …See details»
PolarityTE, Inc., et al. - Verita Global
Welcome to the Restructuring Case for PolarityTE, Inc., et al. Rule 9001(5) of the Federal Rules of Bankruptcy Procedure requires that a representative of the Debtors appear at the Meeting …See details»
PolarityTE, Inc. has Changed its Name to RegenETP, Inc
Aug 18, 2023 PolarityTE, Inc. Auditor Raises 'Going Concern' Doubt 23-03-26: CI Michael Brauser cancelled the acquisition of the remaining stake in PolarityTE, Inc.. 23-03-14: CI …See details»
Sales Agreement dated March 30, 2021, between the Company …
PolarityTE, Inc. Shares of Common Stock (par value $0.001 per share) Controlled Equity Offering SM . Sales Agreement . March 30, 2021 . Cantor Fitzgerald & Co. 499 Park Avenue. New …See details»
POLARITYTE, INC. - Annual Report: 2011 (Form 10-K) | Annual …
Indicate by check mark if the registrant is a well known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes No x. Indicate by check mark if the registrant is not rSee details»
PolarityTE Headquarters and Office Locations - Craft
PolarityTE Headquarters and Office Locations. Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit. Button CTA. PolarityTE is headquartered in Salt Lake City, 123 N …See details»
PolarityTE Secures $22.5 Million Financing to Advance
May 20, 2024 PolarityTE, headquartered in Salt Lake City, Utah, is a biotechnology company developing regenerative tissue products. PolarityTE’s first regenerative tissue product is …See details»
Polarityte MD Revenue, Growth & Competitor Profile - IncFact.com
Mar 10, 2025 Polarityte MD is a publicly traded company on using the ticker symbol COOL. Detailed information on company financials and operating reports can be found here: : COOL …See details»
Polarityte | PTE Stock Price, Company Overview & News - Forbes
Polarityte. PTE. $0.15. 0.00 (0.00%) Share Price. as of March 10 10:12:23 AM EST. Polarityte (PTE) Stock Price Performance. Polarityte (PTE) Stock Key Data. Summary Additional Data …See details»
New therapy offers hope for wound healing in severely burned …
Dec 17, 2019 PolarityTE, Inc., a biotechnology company in Salt Lake City, Utah, USA, has developed a revolutionary new treatment, SkinTE™, for burns and other skin defects, …See details»
PolarityTE: A Comprehensive Look At The Bull Vs. Bear Cases
Oct 25, 2017 PolarityTE “Polarity” is a “novel regenerative medicine and tissue engineering platform” developed by Dr. Denver Lough, the company’s CEO.In this report, we provide …See details»
Settlement Terms Agreement dated August 21, 2019 between
Aug 21, 2019 1. Economic Terms. $1,000,000 $1,500,000 (one million, five hundred thousand dollars) on October 1, 2019 and $1,000,000 $1,500,000 (one million, five hundred thousand …See details»
PolarityTE to raise $8M in registered direct and private placement ...
Jun 6, 2022 PolarityTE (PTE) trades 6.3% down premarket after it entered into securities purchase agreements with a single healthcare-focused institutional investor for the purchase …See details»
PolarityTE, Inc. (PTE) Reports Q1 Loss, Misses Revenue Estimates
May 16, 2022 PolarityTE, Inc. (PTE) delivered earnings and revenue surprises of -25% and 12.82%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what …See details»
PolarityTE Announces U.S. FDA Approval of IND for Pivotal Phase …
SALT LAKE CITY, Jan. 18, 2022 /PRNewswire/ -- PolarityTE, Inc. (Nasdaq: PTE), a biotechnology company developing regenerative tissue products and biomaterials, today …See details»
PolarityTE: Investors Beware - Hindenburg Research
Oct 7, 2017 PolarityTE’s sole key asset is a patent application that it acquired for a value of $104.7 million. Common equity holders are exposed to severe potential dilution, given a …See details»
生物技术和再生生物材料公司：PolarityTE, Inc.(PTE) | 美股之家
PolarityTE(PTE)美股百科. 在2016年12月，Majesco宣布将停止在娱乐业的业务，并与生物技术公司PolarityTE合并，PolarityTE将获得Majesco的 纳斯达克 的股票代码：COOL（后改为PTE …See details»
Lawsuit filed for Investors in shares of PolarityTE, Inc. - openPR.com
Oct 7, 2021 An investigation was announced concerning potential breaches of fiduciary duties by certain directors and officers of PolarityTE, Inc. Investors who are current long term …See details»